Forum for Science, Industry and Business

Sponsored by:     3M 
Search our Site:

 

Melatonin, a hormone segregated by human body, regulates sleep better than somniferous

09.11.2009
Scientists of the University of Granada state that the exogenous administration of melatonin corrects the sleep/wakefulness pace when human biological clock gets altered. At present, this substance is being widely used by the pharmaceutical industry to design synthetic medicines, a very interesting therapeutic tool for the treatment of sleep alterations.

Melatonin, a natural hormone segregated by the own human body, is an excellent sleep regulator expected to replace somniferous, which are much more aggressive, to correct the sleep/wakefulness pace when human biological clock becomes altered.

Those are the conclusions of a research work carried out by Darío Acuña-Castroviejo and Germaine Escames, professors of the Institute of Biotechnology (Biomedical Research Centre of the University of Granada), who have been carrying out a complete analysis of the properties of this natural hormone segregated by the pineal gland for years.

Melatonin (frequently called the ‘hormone of darkness’, because the organism produces it at night) is currently being used by the pharmaceutical industry to design derivative synthetic medicines, a very interesting therapeutic tool for the treatment of sleep alterations. Not in vain, the European Medicines Agency (EMEA) authorized in 2007 the use of melatonin for this type of therapies, after years of debate about the convenience of this measure.

Taking it at specific hours
The researchers of the University of Granada have stated that melatonin “is a very effective chronobiotic in the treatment of chronobiological alterations of the cycle sleep/wakefulness”, although its administration “must take place at certain hours of the day, inducing a phase advance or delay as convenient”. Therefore, the scientists point out that the “lack of effect of melatonin is related, most of the times, to an inadequate administration”.

The authors of this work, published in the Revista de Neurología (2009), state that endogenous melatonin (this is, that segregated by the human organism) “plays an important role in the circadian regulation of sleep”, whereas exogenous melatonin (administered as a medicine) “has an influence on sleep aspects such as latency and quality”.

Actually, the ability of melatonin to readapt the biological clock has been studied in blind individuals, as they cannot make use of the information of the photoperiod to activate the endogenous pacemaker segregated by melatonin at night. The scientists have pointed out that the administration of melatonin every 24 hours (1-10 mg/a day) re-establishes the pace in these persons, including the sleep/wakefulness, synchronizing them to a period of 24 hours.

The use of melatonin to regulate sleep is not the only work carried out at the Institute of Biotechnology of the UGR. In the last years, professors Acuña and Escames have proved that this substance is also useful to slow down cell ageing, to treat diseases such as Parkinson and to slow down cell death caused by serious infectious processes that affect the entire organism technically known as sepsis. Exactly, they are working at present on a clinical test in Phase II to assess the therapeutic of melatonin in the septic shock on patients, funded by the Health Institute Carlos III.

Reference: Professors Darío Acuña Castroviejo and Germaine Escames
Institute of Biotechnology, Biomedical Research Centre of the University of Granada.
Phone number. 958 241000 ext. 20169
E-mail. dacuna@ugr.es; gescames@ugr.es

Darío Acuña Castroviejo | EurekAlert!
Further information:
http://www.ugr.es

More articles from Life Sciences:

nachricht Cryo-electron microscopy achieves unprecedented resolution using new computational methods
24.03.2017 | DOE/Lawrence Berkeley National Laboratory

nachricht How cheetahs stay fit and healthy
24.03.2017 | Forschungsverbund Berlin e.V.

All articles from Life Sciences >>>

The most recent press releases about innovation >>>

Die letzten 5 Focus-News des innovations-reports im Überblick:

Im Focus: Giant Magnetic Fields in the Universe

Astronomers from Bonn and Tautenburg in Thuringia (Germany) used the 100-m radio telescope at Effelsberg to observe several galaxy clusters. At the edges of these large accumulations of dark matter, stellar systems (galaxies), hot gas, and charged particles, they found magnetic fields that are exceptionally ordered over distances of many million light years. This makes them the most extended magnetic fields in the universe known so far.

The results will be published on March 22 in the journal „Astronomy & Astrophysics“.

Galaxy clusters are the largest gravitationally bound structures in the universe. With a typical extent of about 10 million light years, i.e. 100 times the...

Im Focus: Tracing down linear ubiquitination

Researchers at the Goethe University Frankfurt, together with partners from the University of Tübingen in Germany and Queen Mary University as well as Francis Crick Institute from London (UK) have developed a novel technology to decipher the secret ubiquitin code.

Ubiquitin is a small protein that can be linked to other cellular proteins, thereby controlling and modulating their functions. The attachment occurs in many...

Im Focus: Perovskite edges can be tuned for optoelectronic performance

Layered 2D material improves efficiency for solar cells and LEDs

In the eternal search for next generation high-efficiency solar cells and LEDs, scientists at Los Alamos National Laboratory and their partners are creating...

Im Focus: Polymer-coated silicon nanosheets as alternative to graphene: A perfect team for nanoelectronics

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are less stable. Now researchers at the Technical University of Munich (TUM) have, for the first time ever, produced a composite material combining silicon nanosheets and a polymer that is both UV-resistant and easy to process. This brings the scientists a significant step closer to industrial applications like flexible displays and photosensors.

Silicon nanosheets are thin, two-dimensional layers with exceptional optoelectronic properties very similar to those of graphene. Albeit, the nanosheets are...

Im Focus: Researchers Imitate Molecular Crowding in Cells

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to simulate these confined natural conditions in artificial vesicles for the first time. As reported in the academic journal Small, the results are offering better insight into the development of nanoreactors and artificial organelles.

Enzymes behave differently in a test tube compared with the molecular scrum of a living cell. Chemists from the University of Basel have now been able to...

All Focus news of the innovation-report >>>

Anzeige

Anzeige

Event News

International Land Use Symposium ILUS 2017: Call for Abstracts and Registration open

20.03.2017 | Event News

CONNECT 2017: International congress on connective tissue

14.03.2017 | Event News

ICTM Conference: Turbine Construction between Big Data and Additive Manufacturing

07.03.2017 | Event News

 
Latest News

Argon is not the 'dope' for metallic hydrogen

24.03.2017 | Materials Sciences

Astronomers find unexpected, dust-obscured star formation in distant galaxy

24.03.2017 | Physics and Astronomy

Gravitational wave kicks monster black hole out of galactic core

24.03.2017 | Physics and Astronomy

VideoLinks
B2B-VideoLinks
More VideoLinks >>>